Literature DB >> 19409772

Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.

Campbell S D Roxburgh1, Jonathan M Salmond, Paul G Horgan, Karin A Oien, Donald C McMillan.   

Abstract

BACKGROUND: A pronounced tumour inflammatory infiltrate is known to confer a good outcome in colorectal cancer. Klintrup and colleagues reported a structured assessment of the inflammatory reaction at the invasive margin scoring low grade or high grade. The aim of the present study was to examine the prognostic value of tumour inflammatory infiltrate in node-negative colorectal cancer.
METHODS: Two hundred patients had undergone surgery for node-negative colorectal cancer between 1997 and 2004. Specimens were scored with Jass' and Klintrup's criteria for peritumoural infiltrate. Pathological data were taken from the reports at that time.
RESULTS: Low-grade inflammatory infiltrate assessed using Klintrup's criteria was an independent prognostic factor in node-negative disease. In patients with a low-risk Petersen Index (n=179), low-grade infiltrate carried a threefold increased risk of cancer death. Low-grade infiltrate was related to increasing T stage and an infiltrating margin.
CONCLUSION: Assessment of inflammatory infiltrate using Klintrup's criteria provides independent prognostic information on node-negative colorectal cancer. A high-grade local inflammatory response may represent effective host immune responses impeding tumour growth.

Entities:  

Mesh:

Year:  2009        PMID: 19409772     DOI: 10.1016/j.ejca.2009.04.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  Colorectal cancer: sailing with a T-cell EMAST.

Authors:  Ajay Goel
Journal:  Dig Dis Sci       Date:  2011-12-20       Impact factor: 3.199

2.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

Review 3.  The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?

Authors:  Arfon G M T Powell; Paul G Horgan; Joanne Edwards
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-18       Impact factor: 4.553

4.  Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.

Authors:  Vanessa Deschoolmeester; Marc Baay; Filip Lardon; Patrick Pauwels; Marc Peeters
Journal:  Cancer Microenviron       Date:  2011-05-27

5.  Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors.

Authors:  Campbell Roxburgh; Alec McDonald; Jonathan Salmond; Karin Oien; John Anderson; Ruth McKee; Paul Horgan; Donald McMillan
Journal:  Int J Colorectal Dis       Date:  2011-01-07       Impact factor: 2.571

6.  The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.

Authors:  Mario Roselli; Vincenzo Formica; Vittore Cereda; Caroline Jochems; Jacob Richards; Italia Grenga; Augusto Orlandi; Patrizia Ferroni; Fiorella Guadagni; Jeffrey Schlom
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

7.  Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Authors:  Vanessa Deschoolmeester; Marc Baay; Eric Van Marck; Joost Weyler; Peter Vermeulen; Filip Lardon; Jan B Vermorken
Journal:  BMC Immunol       Date:  2010-04-12       Impact factor: 3.615

8.  The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers.

Authors:  Campbell S D Roxburgh; Jonathan M Salmond; Paul G Horgan; Karin A Oien; Donald C McMillan
Journal:  J Gastrointest Surg       Date:  2009-09-19       Impact factor: 3.452

9.  High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome.

Authors:  Leslie Cope; Ren-Chin Wu; Ie-Ming Shih; Tian-Li Wang
Journal:  Gynecol Oncol       Date:  2012-11-28       Impact factor: 5.482

10.  Peritumoral eosinophils predict recurrence in colorectal cancer.

Authors:  Lars Harbaum; Marion J Pollheimer; Peter Kornprat; Richard A Lindtner; Carsten Bokemeyer; Cord Langner
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.